408 related articles for article (PubMed ID: 21398608)
1. Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.
Brancaleone V; Dalli J; Bena S; Flower RJ; Cirino G; Perretti M
J Immunol; 2011 Apr; 186(8):4905-14. PubMed ID: 21398608
[TBL] [Abstract][Full Text] [Related]
2. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.
Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M
J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1-FPR2/ALX anti-inflammatory system.
Gavins FN; Hughes EL; Buss NA; Holloway PM; Getting SJ; Buckingham JC
FASEB J; 2012 Dec; 26(12):4977-89. PubMed ID: 22964301
[TBL] [Abstract][Full Text] [Related]
4. FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.
Maderna P; Cottell DC; Toivonen T; Dufton N; Dalli J; Perretti M; Godson C
FASEB J; 2010 Nov; 24(11):4240-9. PubMed ID: 20570963
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.
Gastardelo TS; Cunha BR; Raposo LS; Maniglia JV; Cury PM; Lisoni FC; Tajara EH; Oliani SM
PLoS One; 2014; 9(12):e111317. PubMed ID: 25490767
[TBL] [Abstract][Full Text] [Related]
6. Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke.
Smith HK; Gil CD; Oliani SM; Gavins FN
FASEB J; 2015 May; 29(5):2161-71. PubMed ID: 25690650
[TBL] [Abstract][Full Text] [Related]
7. Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling.
Bena S; Brancaleone V; Wang JM; Perretti M; Flower RJ
J Biol Chem; 2012 Jul; 287(29):24690-7. PubMed ID: 22610094
[TBL] [Abstract][Full Text] [Related]
8. Mast cells mediate early neutrophil recruitment and exhibit anti-inflammatory properties via the formyl peptide receptor 2/lipoxin A
Hughes EL; Becker F; Flower RJ; Buckingham JC; Gavins FNE
Br J Pharmacol; 2017 Jul; 174(14):2393-2408. PubMed ID: 28471519
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis.
Vong L; Ferraz JG; Dufton N; Panaccione R; Beck PL; Sherman PM; Perretti M; Wallace JL
PLoS One; 2012; 7(6):e39244. PubMed ID: 22723974
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1.
Wan M; Godson C; Guiry PJ; Agerberth B; Haeggström JZ
FASEB J; 2011 May; 25(5):1697-705. PubMed ID: 21307335
[TBL] [Abstract][Full Text] [Related]
11. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement.
Hayhoe RP; Kamal AM; Solito E; Flower RJ; Cooper D; Perretti M
Blood; 2006 Mar; 107(5):2123-30. PubMed ID: 16278303
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro.
Girol AP; Mimura KK; Drewes CC; Bolonheis SM; Solito E; Farsky SH; Gil CD; Oliani SM
J Immunol; 2013 Jun; 190(11):5689-701. PubMed ID: 23645879
[TBL] [Abstract][Full Text] [Related]
13. Definition of a Novel Pathway Centered on Lysophosphatidic Acid To Recruit Monocytes during the Resolution Phase of Tissue Inflammation.
McArthur S; Gobbetti T; Kusters DH; Reutelingsperger CP; Flower RJ; Perretti M
J Immunol; 2015 Aug; 195(3):1139-51. PubMed ID: 26101324
[TBL] [Abstract][Full Text] [Related]
14. Annexin-1 signals mitogen-stimulated breast tumor cell proliferation by activation of the formyl peptide receptors (FPRs) 1 and 2.
Khau T; Langenbach SY; Schuliga M; Harris T; Johnstone CN; Anderson RL; Stewart AG
FASEB J; 2011 Feb; 25(2):483-96. PubMed ID: 20930115
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease.
Costa VV; Sugimoto MA; Hubner J; Bonilha CS; Queiroz-Junior CM; Gonçalves-Pereira MH; Chen J; Gobbetti T; Libanio Rodrigues GO; Bambirra JL; Passos IB; Machado Lopes CE; Moreira TP; Bonjour K; Melo RCN; Oliveira MAP; Andrade MVM; Sousa LP; Souza DG; Santiago HDC; Perretti M; Teixeira MM
Elife; 2022 Mar; 11():. PubMed ID: 35293862
[TBL] [Abstract][Full Text] [Related]
16. Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function.
Planagumà A; Domenech T; Jover I; Ramos I; Sentellas S; Malhotra R; Miralpeix M
Clin Exp Immunol; 2013 Aug; 173(2):298-309. PubMed ID: 23607720
[TBL] [Abstract][Full Text] [Related]
17. Annexin A1 protects against cerebral ischemia-reperfusion injury by modulating microglia/macrophage polarization via FPR2/ALX-dependent AMPK-mTOR pathway.
Xu X; Gao W; Li L; Hao J; Yang B; Wang T; Li L; Bai X; Li F; Ren H; Zhang M; Zhang L; Wang J; Wang D; Zhang J; Jiao L
J Neuroinflammation; 2021 May; 18(1):119. PubMed ID: 34022892
[TBL] [Abstract][Full Text] [Related]
18. Annexin A1, FPR2/ALX, and inflammatory cytokine expression in peritoneal endometriosis.
Volpato LK; Horewicz VV; Bobinski F; Martins DF; Piovezan AP
J Reprod Immunol; 2018 Sep; 129():30-35. PubMed ID: 30096622
[TBL] [Abstract][Full Text] [Related]
19. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄.
Hanson J; Ferreirós N; Pirotte B; Geisslinger G; Offermanns S
Biochem Pharmacol; 2013 Jun; 85(12):1795-802. PubMed ID: 23643932
[TBL] [Abstract][Full Text] [Related]
20. Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation.
Gastardelo TS; Damazo AS; Dalli J; Flower RJ; Perretti M; Oliani SM
Am J Pathol; 2009 Jan; 174(1):177-83. PubMed ID: 19095957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
